Ravinder N. Maini

Sir Ravinder Nath Maini FRCP FRCPE FMedSci (born 17 November 1937) is an Indian-born British rheumatologist and academic who is an emeritus professor at Imperial College London.[1] He led the Kennedy Institute of Rheumatology.[2]

Sir
Ravinder Nath Maini

Sir Ravinder N. Maini in Budapest, 2013.
Born (1937-11-17) 17 November 1937
Alma materSidney Sussex College, Cambridge
Known fordiscovery of anti-TNF therapy as an effective treatment for rheumatoid arthritis
AwardsCrafoord Prize (2000)
Cameron Prize for Therapeutics of the University of Edinburgh (2002)
Albert Lasker Award for Clinical Medical Research (2003)
Dr. Paul Janssen Award for Biomedical Research (2008)
Gairdner Foundation International Award (2014)
Scientific career
FieldsImmunology
InstitutionsImperial College School of Medicine

Biography

Maini was born in Ludhiana, Punjab, British India, to Sir Amar Maini, a Kenyan-born lawyer and Ugandan politician, and his wife, Sam Saheli Mehra. His younger brother is academic Yoginder Nath Tidu Maini. Ravinder completed his bachelor's degree at Sidney Sussex College, Cambridge.[1] In the 1980s, Maini, Marc Feldmann and Fionula Brennan identified TNF alpha as a key cytokine in the process of rheumatoid arthritis.

Honours and awards

He is an honorary member of the British Society for Immunology.[10]

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.